Cargando…
Dry eye in the COVID-19 era: how the measures for controlling pandemic might harm ocular surface
Autores principales: | Giannaccare, Giuseppe, Vaccaro, Sabrina, Mancini, Alessandra, Scorcia, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304378/ https://www.ncbi.nlm.nih.gov/pubmed/32561978 http://dx.doi.org/10.1007/s00417-020-04808-3 |
Ejemplares similares
-
New Perspectives in the Pathophysiology and Treatment of Pain in Patients with Dry Eye Disease
por: Giannaccare, Giuseppe, et al.
Publicado: (2021) -
Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections
por: Vagge, Aldo, et al.
Publicado: (2020) -
False Myths versus Medical Facts: Ten Common Misconceptions Related to Dry Eye Disease
por: Giannaccare, Giuseppe, et al.
Publicado: (2020) -
Effects of a New Formulation of Multiple-Action Tear Substitute on Objective Ocular Surface Parameters and Ocular Discomfort Symptoms in Patients with Dry Eye Disease
por: Vigo, Luca, et al.
Publicado: (2022) -
Ocular-Surface Regeneration Therapies for Eye Disorders: The State of the Art
por: Posarelli, Matteo, et al.
Publicado: (2023)